Brightmeds

Brightmeds offers direct-to-consumer telehealth services for weight loss, hormone therapy, erectile dysfunction, and longevity. Patients complete an online intake reviewed by licensed U.S. physicians; if eligible, prescriptions are sent to certified partner pharmacies and shipped directly to patients. The company emphasizes accessibility, affordability, and ongoing physician support. It does not develop or manufacture drugs but facilitates access to FDA-approved treatments such as semaglutide (Wegovy/Ozempic), tirzepatide (Mounjaro/Zepbound), among others. Clinical results referenced include significant average body weight reductions in trials of these medications.